57 assets in Ewing Sarcoma

Therapeutic assets addressing Ewing Sarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Second Generation 4-1Bbζ Egfr806-Egfrt Ewing Sarcoma	Seattle Children's Hospital	P1	CC (41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg Ewing Sarcoma	Seattle Children's Hospital	P1	CC (41)
st-01156 Ewing Sarcoma	SEED Therapeutics, Inc.	P1	CC (41)
Tipiracil Ewing Sarcoma	Inhibrx Biosciences, Inc	P1	CC (41)
Trifluridine Ewing Sarcoma	Inhibrx Biosciences, Inc	P1	CC (41)
Val-413 Ewing Sarcoma	Valent Technologies, LLC	P1	CC (41)
Vorinostat Ewing Sarcoma	New York Medical College	P1	CC (41)

Showing 51 to 57 of 57 assets

PreviousPage 2 of 2Next